The Stakes In The Texas Abortion Medication Suit Are Broader Than Just One Pill

Authors

Rachel Sachs, Washington University in St. Louis School of LawFollow
Greer Donley, University of Pittsburgh School of LawFollow

Document Type

Editorial

Publication Date

2023

Publication Title

Washington Post

Abstract

The lawsuit in Texas filed with the goal of removing a common abortion medication, mifepristone, from the market nationwide has the potential to disrupt the drug approval and development system more broadly. This could affect patients’ access to a variety of medications and weaken pharmaceutical companies’ incentives to develop new drugs.

Keywords

Abortion, Mifepristone, FDA, Drug Approval, Pharmaceutical Regulation

Publication Citation

Greer Donley and Rachel Sachs, Editorial, The Stakes In The Texas Abortion Medication Suit Are Broader Than Just One Pill, Wash. Post, Mar. 3, 2023

Repository Citation

Sachs, Rachel and Donley, Greer, "The Stakes In The Texas Abortion Medication Suit Are Broader Than Just One Pill" (2023). Scholarship@WashULaw. 55.
https://openscholarship.wustl.edu/law_scholarship/55